|
2025
|
Invention
|
Antibiotic rifabutin analogs. The present invention relates to antibiotic rifabutin analogs of fo... |
|
|
Invention
|
Rifabutin treatment methods, uses, and compositions.
The invention provides formulations contain... |
|
|
Invention
|
Lyophilized formulations of rifabutin. The invention provides solutions for lyophilization, a lyo... |
|
|
Invention
|
Purification of rifabutin formulations. The invention provides compositions and methods of creati... |
|
|
Invention
|
Intravenous rifabutin formulation and methods of making.
The invention provides compositions and... |
|
2024
|
Invention
|
Novel compounds.
The invention relates to compounds of Formula (I) and their use in therapy, for... |
|
|
Invention
|
Rifabutin analogs for the treatment of bacterial diseases.
The present invention relates to comp... |
|
|
Invention
|
Rifabutin analogs for the treatment of bacterial diseases |
|
|
Invention
|
Rifabutin analogs for the treatment of bacterial diseases. Mycobacteria,M. abscessus.M. abscessus. |
|
|
Invention
|
Rifabutin treatment methods, uses, and compositions. The invention provides formulations containi... |
|
2023
|
Invention
|
Rifabutin treatment methods, uses, and compositions. max is that greater than about 2 mg/L and op... |
|
|
Invention
|
Rifabutin analogs for the treatment of disease.
The present invention relates to compounds and p... |
|
|
Invention
|
Rifabutin analogs for the treatment of disease |
|
|
Invention
|
Rifabutin analogs for the treatment of disease. MycobacteriaM. abscessusM. abscessus. |
|
|
Invention
|
Antibiotic combination therapies. A. baumannii infection in a subject. The combination therapies ... |
|
|
Invention
|
3-(phenylsulfonyl)-[1,2,3]triazolo[1,5a]quinazolin-5(4h)-one derivatives.
The present invention ... |
|
|
Invention
|
8-heterocyclic-3-(phenylsulfonyl)-[1,2,3]triazolo[1,5a]quinazolin-5(4h)-one derivatives as anti-b... |
|
|
Invention
|
3-(phenylsulfonyl)-[1,2,3]triazolo[1,5a]quinazolin-5(4h)-one derivatives. The present invention r... |
|
|
Invention
|
3-(phenylsulfonyl)-[1,2,3]triazolo[1,5a]quinazolin-5(4h)-one derivatives. Staphylococcus aureusS.... |
|
|
Invention
|
Antibiotic combination therapies. The invention provides antibiotic combination therapies for tre... |
|
|
Invention
|
Antibiotic combination therapies. A. baumanniiA. baumannii infection in a subject. The combinatio... |
|
|
Invention
|
Substituted pyrrolo[2,3-d]pyrimidines as antimicrobials. The present disclosure relates generally... |
|
|
Invention
|
Rifabutin analogs for the treatment of disease. MycobacteriaMabscessus.abscessus. |
|
|
Invention
|
Rifabutin analogs for the treatment of disease. The present invention relates to compounds and ph... |
|
|
Invention
|
Rifamycin derivatives for the treatment of diseases.
The present disclosure relates to compounds... |
|
|
Invention
|
Rifamycin derivatives for the treatment of diseases. The present disclosure relates to compounds ... |
|
|
Invention
|
Rifamycin derivatives for the treatment of diseases. Acinetobacter Clostridium Enterococcus Hemop... |
|
2022
|
Invention
|
Rifabutin analogs for the treatment of disease.
The present disclosure relates to compounds and ... |
|
|
Invention
|
Rifabutin analogs for the treatment of disease. The present disclosure relates to compounds and p... |
|
|
Invention
|
Rifabutin analogs for the treatment of disease. MycobacteriaM. abscessus.M. abscessus. |
|
|
Invention
|
Antibiotic combination therapies.
The invention provides antibiotic combination therapies for tr... |
|
2021
|
Invention
|
Antimicrobials methods of making and using the same. The present disclosure relates generally to ... |
|
|
Invention
|
Antimicrobial compounds and methods of making and using the same. The present disclosure relates ... |
|
2020
|
Invention
|
Rifabutin treatment methods, uses, and compositions. The invention provides systems and methods f... |
|
|
Invention
|
Antibiotic combination therapy consisting of rifabutin and a polymyxin or cefiderocol. The invent... |
|
2019
|
Invention
|
Pyrrolo[2,3-d]pyrimidin-2-one antimicrobial compounds.
The present disclosure relates generally ... |
|
|
Invention
|
Biodefense agents. The present disclosure relates to methods of treating, preventing, reducing th... |
|
|
Invention
|
Aminomethylamidine and methylamidine antimicrobial compounds.
The present disclosure relates gen... |
|
|
Invention
|
Bacterial vectors for genetic manipulation of bacteria.
The present invention relates to the fie... |
|
|
Invention
|
Antimicrobial compounds and methods of making and using the same.
The present disclosure relates... |
|
2018
|
Invention
|
Antimicrobials and methods of making and using same.
The present disclosure relates generally to... |
